Simon Ferrer-Mendez

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

NOTCHing the MSC-endothelial interplay in the HSC niche.

NOTCHing the MSC-endothelial interplay in the HSC niche.

Journal: Blood

Published: August 13, 2026

A niche for every stem cell in myeloproliferative neoplasms.

A niche for every stem cell in myeloproliferative neoplasms.

Journal: Blood

Published: March 12, 2026

An AI model of transplantation risk for myelofibrosis.

An AI model of transplantation risk for myelofibrosis.

Journal: Blood

Published: June 26, 2025

Stem Cell Niche: iPSC-Based Assembloids for Modeling Human Hematopoiesis.

Stem Cell Niche: iPSC-Based Assembloids for Modeling Human Hematopoiesis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 03, 2025

Ins and outs of HSCs and VEGF-induced vascular remodeling: Toward improved HSC mobilization and engraftment.

Ins and outs of HSCs and VEGF-induced vascular remodeling: Toward improved HSC mobilization and engraftment.

Journal: Stem cell reports

Published: May 30, 2025

NO-immune privilege for hematopoietic stem cells.

NO-immune privilege for hematopoietic stem cells.

Journal: Cell research

Published: February 27, 2025

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.

Journal: Cell reports

Published: January 07, 2025

Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.

Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.

Journal: Blood

Published: October 28, 2024

Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.

Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.

Journal: Research square

Published: August 16, 2024

Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia.

Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia.

Journal: Cell reports

Published: March 04, 2024

The Inflamed Niche: A Double-Edged Sword in AML?

The Inflamed Niche: A Double-Edged Sword in AML?

Journal: Blood cancer discovery

Published: September 01, 2023

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.

Journal: Blood advances

Published: August 01, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026